Bausch Health Companies Inc (BHC.TO)
9.64
-0.01
(-0.10%)
CAD |
TSX |
May 16, 16:00
Bausch Health Revenue (Quarterly): 2.902B for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.902B |
| December 31, 2023 | 3.278B |
| September 30, 2023 | 3.003B |
| June 30, 2023 | 2.913B |
| March 31, 2023 | 2.630B |
| December 31, 2022 | 2.966B |
| September 30, 2022 | 2.668B |
| June 30, 2022 | 2.508B |
| March 31, 2022 | 2.429B |
| December 31, 2021 | 2.767B |
| September 30, 2021 | 2.658B |
| June 30, 2021 | 2.578B |
| March 31, 2021 | 2.565B |
| December 31, 2020 | 2.883B |
| September 30, 2020 | 2.847B |
| June 30, 2020 | 2.306B |
| March 31, 2020 | 2.699B |
| December 31, 2019 | 2.936B |
| September 30, 2019 | 2.917B |
| June 30, 2019 | 2.879B |
| March 31, 2019 | 2.681B |
| December 31, 2018 | 2.804B |
| September 30, 2018 | 2.792B |
| June 30, 2018 | 2.745B |
| March 31, 2018 | 2.520B |
| Date | Value |
|---|---|
| December 31, 2017 | 2.751B |
| September 30, 2017 | 2.782B |
| June 30, 2017 | 3.004B |
| March 31, 2017 | 2.792B |
| December 31, 2016 | 3.206B |
| September 30, 2016 | 3.233B |
| June 30, 2016 | 3.118B |
| March 31, 2016 | 3.258B |
| December 31, 2015 | 3.684B |
| September 30, 2015 | 3.646B |
| June 30, 2015 | 3.359B |
| March 31, 2015 | 2.688B |
| December 31, 2014 | 2.527B |
| September 30, 2014 | 2.238B |
| June 30, 2014 | 2.226B |
| March 31, 2014 | 2.079B |
| December 31, 2013 | 2.166B |
| September 30, 2013 | 1.601B |
| June 30, 2013 | 1.121B |
| March 31, 2013 | 1.076B |
| December 31, 2012 | 912.01M |
| September 30, 2012 | 880.45M |
| June 30, 2012 | 828.16M |
| March 31, 2012 | 857.32M |
| December 31, 2011 | 667.77M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.306B
Minimum
Jun 2020
3.278B
Maximum
Dec 2023
2.767B
Average
2.807B
Median
Revenue (Quarterly) Benchmarks
| Bausch & Lomb Corp | 1.482B |
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -86.28M |
| Total Expenses (Quarterly) | 2.506B |
| EPS Diluted (Quarterly) | -0.2292 |
| Enterprise Value | 33.70B |
| Gross Profit Margin (Quarterly) | 70.27% |
| Profit Margin (Quarterly) | -2.97% |
| Earnings Yield | -17.29% |
| Operating Earnings Yield | 63.92% |
| Normalized Earnings Yield | -2.436 |